Astromech reached a valuation of $3.8 billion, approximately €3.2 billion, nearly doubling the value recorded just four months ago. The company has developed artificial intelligence tools aimed at predicting biological outcomes, representing a convergence between AI and the life sciences.
Astromech is an artificial intelligence startup that emerged from Colossal Biosciences. It is led by Ben Lamm, who also serves as CEO of Colossal. The company specialized in predictive biology, attempting to build AI models capable of anticipating how biology and evolution work. The article suggests that this predictive capability is what makes the company so valuable in the current technological landscape.
